182 related articles for article (PubMed ID: 22699677)
1. CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.
de Oliveira KB; Guembarovski RL; Guembarovski AM; da Silva do Amaral Herrera AC; Sobrinho WJ; Ariza CB; Watanabe MA
Clin Exp Med; 2013 Aug; 13(3):211-9. PubMed ID: 22699677
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients.
de Oliveira KB; Guembarovski RL; Oda JM; Mantovani MS; Carrera CM; Reiche EM; Voltarelli JC; da Silva do Amaral Herrera AC; Watanabe MA
Cytokine; 2011 Aug; 55(2):260-5. PubMed ID: 21592819
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 3: implications for proinflammatory microenvironment in human breast cancer.
Amarante MK; de Oliveira KB; Guembarovski RL; da Silva do Amaral Herrera AC; Guembarovski AL; Sobrinho WJ; Voltarelli JC; Watanabe MA
Mol Biol Rep; 2012 Dec; 39(12):11087-92. PubMed ID: 23053995
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.
Zhou W; Jiang Z; Liu N; Xu F; Wen P; Liu Y; Zhong W; Song X; Chang X; Zhang X; Wei G; Yu J
J Cancer Res Clin Oncol; 2009 Jan; 135(1):91-102. PubMed ID: 18670789
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu W; Qian L; Chen X; Ding B
Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor CXCR4 and its ligand CXCL12 expressions and clinical significance in bladder cancer.
Yang DL; Xin MM; Wang JS; Xu HY; Huo Q; Tang ZR; Wang HF
Genet Mol Res; 2015 Dec; 14(4):17699-707. PubMed ID: 26782415
[TBL] [Abstract][Full Text] [Related]
7. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
8. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
[TBL] [Abstract][Full Text] [Related]
9. COUP-TFI modifies CXCL12 and CXCR4 expression by activating EGF signaling and stimulates breast cancer cell migration.
Boudot A; Kerdivel G; Lecomte S; Flouriot G; Desille M; Godey F; Leveque J; Tas P; Le Dréan Y; Pakdel F
BMC Cancer; 2014 Jun; 14():407. PubMed ID: 24906407
[TBL] [Abstract][Full Text] [Related]
10. Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia.
Butrym A; Gebura K; Iwaszko M; Kuliczkowski K; Bogunia-Kubik K; Mazur G
HLA; 2016 Jun; 87(6):432-8. PubMed ID: 27173875
[TBL] [Abstract][Full Text] [Related]
11. CXCL12-CXCR4 axis promotes the natural selection of breast cancer cell metastasis.
Sun Y; Mao X; Fan C; Liu C; Guo A; Guan S; Jin Q; Li B; Yao F; Jin F
Tumour Biol; 2014 Aug; 35(8):7765-73. PubMed ID: 24810923
[TBL] [Abstract][Full Text] [Related]
12. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer.
Guembarovski AL; Guembarovski RL; Hirata BKB; Vitiello GAF; Suzuki KM; Enokida MT; Watanabe MAE; Reiche EMV
Mol Biol Rep; 2018 Oct; 45(5):741-750. PubMed ID: 29926386
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
[TBL] [Abstract][Full Text] [Related]
15. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma.
de Oliveira KB; Oda JM; Voltarelli JC; Nasser TF; Ono MA; Fujita TC; Matsuo T; Watanabe MA
J Clin Lab Anal; 2009; 23(6):387-93. PubMed ID: 19927352
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.
Ramos EA; Grochoski M; Braun-Prado K; Seniski GG; Cavalli IJ; Ribeiro EM; Camargo AA; Costa FF; Klassen G
PLoS One; 2011; 6(12):e29461. PubMed ID: 22220212
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis.
Martinez-Ordoñez A; Seoane S; Cabezas P; Eiro N; Sendon-Lago J; Macia M; Garcia-Caballero T; Gonzalez LO; Sanchez L; Vizoso F; Perez-Fernandez R
Oncogene; 2018 Mar; 37(11):1430-1444. PubMed ID: 29321662
[TBL] [Abstract][Full Text] [Related]
18. Association of rs1801157 single nucleotide polymorphism of CXCL12 gene in breast cancer in Pakistan and
Khalid S; Hanif R
PeerJ; 2017; 5():e3822. PubMed ID: 28929029
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.
Douglass S; Meeson AP; Overbeck-Zubrzycka D; Brain JG; Bennett MR; Lamb CA; Lennard TW; Browell D; Ali S; Kirby JA
J Pathol; 2014 Sep; 234(1):74-85. PubMed ID: 24870556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]